Bicycle Therapeutics Plc
(NASDAQ) BCYC
Bicycle Therapeutics Plc Financials at a Glance
Market Cap
$217.20M
Revenue (TTM)
$72.59M
Net Income (TTM)
$218.96M
EPS (TTM)
$-3.17
P/E Ratio
-1.37
Dividend
$0.00
Beta (Volatility)
1.15 (Average)
Dividend
$0.00
Beta (Volatility)
1.15 (Average)
Price
$4.35
Volume
28,548
Open
$4.50
Price
$4.35
Volume
28,548
Open
$4.50
Previous Close
$4.35
Daily Range
$4.30 - $4.57
52-Week Range
$4.29 - $9.69
Dividend
$0.00
Beta (Volatility)
1.15 (Average)
Price
$4.35
Volume
28,548
Open
$4.50
Previous Close
$4.35
Daily Range
$4.30 - $4.57
52-Week Range
$4.29 - $9.69
BCYC News
Is Bicycle Therapeutics Stock a Buy?
BCYC: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Bicycle Therapeutics Plc
Industry
Biotechnology
Sector
Health CareEmployees
288
CEO
Kevin Lee, PhD, MBA
Website
bicycletherapeutics.comHeadquarters
Cambridge, CB22 3AT, GB
BCYC Financials
Key Financial Metrics (TTM)
Gross Margin
-1%
Operating Margin
-4%
Net Income Margin
-3%
Return on Equity
-31%
Return on Capital
-43%
Return on Assets
-31%
Earnings Yield
-72.99%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$217.20M
Shares Outstanding
49.93M
Volume
28.55K
Short Interest
0.00%
Avg. Volume
364.43K
Financials (TTM)
Gross Profit
$66.32M
Operating Income
$283.30M
EBITDA
$247.06M
Operating Cash Flow
$249.68M
Capital Expenditure
$2.36M
Free Cash Flow
$249.68M
Cash & ST Invst.
$628.11M
Total Debt
$14.10M
Bicycle Therapeutics Plc Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$47.95M
+1193.3%
Gross Profit
$12.90M
+124.6%
Gross Margin
26.89%
N/A
Market Cap
$217.20M
N/A
Market Cap/Employee
$712.12K
N/A
Employees
305
N/A
Net Income
$20.15M
+61.1%
EBITDA
$29.74M
+54.9%
Quarterly Fundamentals
Net Cash
$614.01M
-29.4%
Accounts Receivable
$35.59M
-0.2%
Inventory
$0.00
N/A
Long Term Debt
$28.86M
+623.3%
Short Term Debt
$2.76M
-49.9%
Return on Assets
-30.51%
N/A
Return on Invested Capital
-42.88%
N/A
Free Cash Flow
$17.24M
-76.5%
Operating Cash Flow
$19.01M
-103.1%